CN107849057B - 用于合成软海绵素大环内酯的大环化反应及中间体和其他片段 - Google Patents

用于合成软海绵素大环内酯的大环化反应及中间体和其他片段 Download PDF

Info

Publication number
CN107849057B
CN107849057B CN201680040015.8A CN201680040015A CN107849057B CN 107849057 B CN107849057 B CN 107849057B CN 201680040015 A CN201680040015 A CN 201680040015A CN 107849057 B CN107849057 B CN 107849057B
Authority
CN
China
Prior art keywords
protecting group
formula
independently
alkyl
hydroxy protecting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201680040015.8A
Other languages
English (en)
Chinese (zh)
Other versions
CN107849057A (zh
Inventor
F.G.方
C.E.查塞
D-S.金
H-W.蔡
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanitary Material R&d Management Co ltd
Original Assignee
Sanitary Material R&d Management Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanitary Material R&d Management Co ltd filed Critical Sanitary Material R&d Management Co ltd
Priority to CN202310983219.7A priority Critical patent/CN117024469A/zh
Priority to CN202011142074.0A priority patent/CN112250692B/zh
Publication of CN107849057A publication Critical patent/CN107849057A/zh
Application granted granted Critical
Publication of CN107849057B publication Critical patent/CN107849057B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/22—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • C07F7/1872—Preparation; Treatments not provided for in C07F7/20
    • C07F7/1892—Preparation; Treatments not provided for in C07F7/20 by reactions not provided for in C07F7/1876 - C07F7/1888
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/6552—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
CN201680040015.8A 2015-05-07 2016-05-09 用于合成软海绵素大环内酯的大环化反应及中间体和其他片段 Active CN107849057B (zh)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CN202310983219.7A CN117024469A (zh) 2015-05-07 2016-05-09 可用于合成软海绵素大环内酯的大环化反应以及中间体和其他片段
CN202011142074.0A CN112250692B (zh) 2015-05-07 2016-05-09 可用于合成软海绵素大环内酯的大环化反应以及中间体和其他片段

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201562158506P 2015-05-07 2015-05-07
US62/158506 2015-05-07
US201662291918P 2016-02-05 2016-02-05
US62/291918 2016-02-05
PCT/US2016/031546 WO2016179607A1 (en) 2015-05-07 2016-05-09 Macrocyclization reactions and intermediates and other fragments useful in the synthesis of halichondrin macrolides

Related Child Applications (2)

Application Number Title Priority Date Filing Date
CN202011142074.0A Division CN112250692B (zh) 2015-05-07 2016-05-09 可用于合成软海绵素大环内酯的大环化反应以及中间体和其他片段
CN202310983219.7A Division CN117024469A (zh) 2015-05-07 2016-05-09 可用于合成软海绵素大环内酯的大环化反应以及中间体和其他片段

Publications (2)

Publication Number Publication Date
CN107849057A CN107849057A (zh) 2018-03-27
CN107849057B true CN107849057B (zh) 2020-11-10

Family

ID=57218352

Family Applications (3)

Application Number Title Priority Date Filing Date
CN201680040015.8A Active CN107849057B (zh) 2015-05-07 2016-05-09 用于合成软海绵素大环内酯的大环化反应及中间体和其他片段
CN202310983219.7A Pending CN117024469A (zh) 2015-05-07 2016-05-09 可用于合成软海绵素大环内酯的大环化反应以及中间体和其他片段
CN202011142074.0A Active CN112250692B (zh) 2015-05-07 2016-05-09 可用于合成软海绵素大环内酯的大环化反应以及中间体和其他片段

Family Applications After (2)

Application Number Title Priority Date Filing Date
CN202310983219.7A Pending CN117024469A (zh) 2015-05-07 2016-05-09 可用于合成软海绵素大环内酯的大环化反应以及中间体和其他片段
CN202011142074.0A Active CN112250692B (zh) 2015-05-07 2016-05-09 可用于合成软海绵素大环内酯的大环化反应以及中间体和其他片段

Country Status (9)

Country Link
US (2) US10308661B2 (cg-RX-API-DMAC7.html)
EP (1) EP3292130B1 (cg-RX-API-DMAC7.html)
JP (1) JP6840090B2 (cg-RX-API-DMAC7.html)
KR (2) KR102743950B1 (cg-RX-API-DMAC7.html)
CN (3) CN107849057B (cg-RX-API-DMAC7.html)
IL (2) IL255408B (cg-RX-API-DMAC7.html)
MX (2) MX392296B (cg-RX-API-DMAC7.html)
RU (2) RU2739034C2 (cg-RX-API-DMAC7.html)
WO (1) WO2016179607A1 (cg-RX-API-DMAC7.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101434673B1 (ko) 2004-06-03 2014-08-26 에자이 알앤드디 매니지먼트 가부시키가이샤 할리콘드린 b 유사체의 제조를 위한 중간체
EP2578576B9 (en) 2007-10-03 2016-09-14 Eisai R&D Management Co., Ltd. Intermediates for the synthesis of halichondrin B analogs
US8203010B2 (en) 2010-01-26 2012-06-19 Eisai R&D Management Co., Ltd. Compounds useful in the synthesis of halichondrin B analogs
CA2929084C (en) 2013-11-04 2022-01-11 Eisai R&D Management Co., Ltd. Macrocyclization reactions and intermediates and other fragments useful in the synthesis of analogs of halichondrin b
BR112016012237B1 (pt) 2013-12-06 2023-02-07 Eisai R&D Management Co., Ltd Métodos úteis na síntese de análogos de halicondrina b
WO2016003975A1 (en) 2014-06-30 2016-01-07 President And Fellows Of Harvard College Synthesis of halichondrin analogs and uses thereof
WO2016176560A1 (en) 2015-04-30 2016-11-03 President And Fellows Of Harvard College Chromium-mediated coupling and application to the synthesis of halichondrins
MX392296B (es) 2015-05-07 2025-03-24 Eisai R&D Man Co Ltd Reacciones de macrociclizacion e intermediarios y otros fragmentos utiles en la sintesis de macrolidos de halicondrina.
MX377663B (es) 2016-02-12 2025-03-11 Eisai R&D Man Co Ltd Intermediarios en la sintesis de eribulina y metodos de sintesis relacionados.
US11136335B2 (en) * 2016-06-30 2021-10-05 Eisai R&D Management Co., Ltd. Prins reaction and intermediates useful in the synthesis of halichondrin macrolides and analogs thereof
JP6978758B2 (ja) 2016-11-11 2021-12-08 プレジデント アンド フェローズ オブ ハーバード カレッジ パラジウム媒介ケトール化
SI3606928T1 (sl) 2017-04-05 2023-02-28 President And Fellows Of Harvard College Makrociklična spojina in njene uporabe
US9938288B1 (en) 2017-04-05 2018-04-10 President And Fellows Of Harvard College Macrocyclic compound and uses thereof
US11498892B2 (en) 2017-07-06 2022-11-15 President And Fellows Of Harvard College Fe/Cu-mediated ketone synthesis
HUE061306T2 (hu) * 2017-07-06 2023-06-28 Harvard College Halikondrinok szintézise
CN111566113B (zh) 2017-11-15 2024-01-09 哈佛大学的校长及成员们 大环化合物及其用途
MX2020006945A (es) * 2018-01-03 2020-11-09 Eisai R&D Man Co Ltd Reaccion de prins y compuestos utiles en la sintesis de macrolidos de halicondrina y analogos de los mismos.
CN115583875B (zh) * 2022-09-28 2023-12-01 联化科技(台州)有限公司 在连续流反应器中将烯丙型醇氧化为α,β-不饱和醛酮的方法

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1312804A (zh) * 1998-06-17 2001-09-12 卫材株式会社 大环类似物及其使用和制备的方法
WO2005118565A1 (en) * 2004-06-03 2005-12-15 Eisai Co., Ltd. Intermediates for the preparation of halichondrin b
WO2008010776A1 (en) * 2006-07-21 2008-01-24 Agency For Science, Technology And Research Aigialomycin d and derivatives thereof and their use in treating cancer or malaria or a microbial infection
WO2012147900A1 (en) * 2011-04-28 2012-11-01 Eisai R&D Management Co., Ltd. Microreactor process for halichondrin b analog synthesis
CN102803254A (zh) * 2010-01-26 2012-11-28 卫材R&D管理有限公司 用于软海绵素b类似物合成的呋喃并[3,2-b]吡喃衍生物
WO2013078559A1 (en) * 2011-11-30 2013-06-06 Alphora Research Inc. Process for preparation of (3r)-2,4-di-leaving group-3-methylbut-1-ene
CN104334562A (zh) * 2012-03-30 2015-02-04 阿方拉研究股份有限公司 用于制备软海绵素b的大环c1-酮类似物的合成方法及其中有用的中间体

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU652180A1 (ru) 1975-12-16 1979-03-15 Краснодарский политехнический институт 1(Фурил-2,)-2-(2-,, формилфурил-5,, ) этилен или его метильное производное как промежуточный продукт дл синтеза фуран-2,5-дикарбоновой кислоты и способ его получени
US5436238A (en) 1992-03-12 1995-07-25 President And Fellows Of Harvard College Halichondrins and related compounds
US5338865A (en) * 1992-03-12 1994-08-16 President And Fellows Of Harvard College Synthesis of halichondrin B and norhalichondrin B
GB9206244D0 (en) 1992-03-23 1992-05-06 Pharma Mar Sa Cytotoxic compound from a marine sponge
TW255880B (cg-RX-API-DMAC7.html) 1992-09-09 1995-09-01 Hoechst Ag
WO1998009942A1 (en) 1996-09-06 1998-03-12 Eli Lilly And Company Catalytic selective sulfonylation process
US6870058B2 (en) 1996-12-03 2005-03-22 The Trustees Of The University Of Pennsylvania Compounds which mimic the chemical and biological properties of discodermolide
US6653341B1 (en) 1998-06-17 2003-11-25 Eisai Co., Ltd. Methods and compositions for use in treating cancer
US8097648B2 (en) 1998-06-17 2012-01-17 Eisai R&D Management Co., Ltd. Methods and compositions for use in treating cancer
DE10106647A1 (de) 2001-02-12 2002-08-22 Univ Hannover Ratjadon-Derivate zum Hemmen des Zellwachstums
US20060045846A1 (en) 2004-08-30 2006-03-02 Horstmann Thomas E Reagents and methods for labeling terminal olefins
JP2008522623A (ja) 2004-12-09 2008-07-03 エーザイ株式会社 ハリコンドリンbアナログを使用した癌治療でのチューブリンアイソタイプのスクリーニング
EP1940758B1 (en) 2005-09-26 2012-11-28 Symrise AG Intramolecular prins reaction
JPWO2009014105A1 (ja) 2007-07-20 2010-10-07 株式会社山田養蜂場本社 新規カルボン酸およびそれを有効成分とする抗うつ用組成物
EP2578576B9 (en) 2007-10-03 2016-09-14 Eisai R&D Management Co., Ltd. Intermediates for the synthesis of halichondrin B analogs
CN101910180A (zh) 2007-11-16 2010-12-08 卫材R&D管理有限公司 用于软海绵素b类似物合成的新颖中间体和用于该中间体的新颖脱磺酰化反应
RU2517167C2 (ru) 2008-04-04 2014-05-27 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Аналоги галихондрина в
JP5371091B2 (ja) 2009-01-23 2013-12-18 三菱レイヨン株式会社 モノスルホン酸エステルの製造方法
WO2015000070A1 (en) 2013-07-03 2015-01-08 Alphora Research Inc. Synthetic process for preparation of macrocyclic c1-keto analogs of halichondrin b and intermediates useful therein including intermediates containing -so2-(p-tolyl) groups
CA2929084C (en) 2013-11-04 2022-01-11 Eisai R&D Management Co., Ltd. Macrocyclization reactions and intermediates and other fragments useful in the synthesis of analogs of halichondrin b
BR112016012237B1 (pt) 2013-12-06 2023-02-07 Eisai R&D Management Co., Ltd Métodos úteis na síntese de análogos de halicondrina b
US10208058B2 (en) 2014-09-09 2019-02-19 Cipla Limited Process for the preparation of macrocyclic ketone analogs of halichondrin B or pharmaceutically acceptable salts and intermediates thereof
MX392296B (es) 2015-05-07 2025-03-24 Eisai R&D Man Co Ltd Reacciones de macrociclizacion e intermediarios y otros fragmentos utiles en la sintesis de macrolidos de halicondrina.
MX377663B (es) 2016-02-12 2025-03-11 Eisai R&D Man Co Ltd Intermediarios en la sintesis de eribulina y metodos de sintesis relacionados.
US11136335B2 (en) 2016-06-30 2021-10-05 Eisai R&D Management Co., Ltd. Prins reaction and intermediates useful in the synthesis of halichondrin macrolides and analogs thereof
WO2018217894A1 (en) 2017-05-24 2018-11-29 Eisai R&D Management Co., Ltd. Fluorine-labelled halichondrin derivatives and related methods of synthesis
MX2020006945A (es) 2018-01-03 2020-11-09 Eisai R&D Man Co Ltd Reaccion de prins y compuestos utiles en la sintesis de macrolidos de halicondrina y analogos de los mismos.

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1312804A (zh) * 1998-06-17 2001-09-12 卫材株式会社 大环类似物及其使用和制备的方法
WO2005118565A1 (en) * 2004-06-03 2005-12-15 Eisai Co., Ltd. Intermediates for the preparation of halichondrin b
CN101899026A (zh) * 2004-06-03 2010-12-01 卫材R&D管理有限公司 用于制备软海绵素b的中间体
WO2008010776A1 (en) * 2006-07-21 2008-01-24 Agency For Science, Technology And Research Aigialomycin d and derivatives thereof and their use in treating cancer or malaria or a microbial infection
CN102803254A (zh) * 2010-01-26 2012-11-28 卫材R&D管理有限公司 用于软海绵素b类似物合成的呋喃并[3,2-b]吡喃衍生物
WO2012147900A1 (en) * 2011-04-28 2012-11-01 Eisai R&D Management Co., Ltd. Microreactor process for halichondrin b analog synthesis
WO2013078559A1 (en) * 2011-11-30 2013-06-06 Alphora Research Inc. Process for preparation of (3r)-2,4-di-leaving group-3-methylbut-1-ene
CN104334562A (zh) * 2012-03-30 2015-02-04 阿方拉研究股份有限公司 用于制备软海绵素b的大环c1-酮类似物的合成方法及其中有用的中间体

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
"Symmetric Macrocycles by a Prins Dimerization and Macrocyclization Strategy";Michael R. Gesinski et al.;《ORGANIC LETTERS》;20091029;第11卷(第22期);第5342-5345页 *
"Total Synthesis of (+)-Trienomycins A and F via C−C Bond-Forming Hydrogenation and Transfer Hydrogenation";David J. Del Valle et al.;《Journal of the American Chemical Society》;20130717;第135卷;第10986-10989页 *
"Total Synthesis of Halichondrin C";Akihiko Yamamoto et al.;《Journal of the American Chemical Society》;20111220;第134卷;第893-896页 *

Also Published As

Publication number Publication date
IL276376A (en) 2020-09-30
US20180118755A1 (en) 2018-05-03
IL276376B (en) 2021-09-30
KR20180013943A (ko) 2018-02-07
MX2017014237A (es) 2018-09-17
JP2018516885A (ja) 2018-06-28
EP3292130B1 (en) 2020-09-30
MX380284B (es) 2025-03-12
RU2017142100A (ru) 2019-06-07
US10913749B2 (en) 2021-02-09
RU2017142100A3 (cg-RX-API-DMAC7.html) 2019-12-26
IL255408A0 (en) 2017-12-31
IL255408B (en) 2020-08-31
RU2739034C2 (ru) 2020-12-21
CN107849057A (zh) 2018-03-27
CN112250692B (zh) 2023-08-29
JP6840090B2 (ja) 2021-03-10
CN112250692A (zh) 2021-01-22
RU2020141025A (ru) 2020-12-28
KR102743950B1 (ko) 2024-12-18
US20190308992A1 (en) 2019-10-10
MX2021002629A (es) 2022-05-13
US10308661B2 (en) 2019-06-04
MX392296B (es) 2025-03-24
CN117024469A (zh) 2023-11-10
KR20250012090A (ko) 2025-01-23
EP3292130A1 (en) 2018-03-14
WO2016179607A1 (en) 2016-11-10
EP3292130A4 (en) 2018-12-05

Similar Documents

Publication Publication Date Title
CN112250692B (zh) 可用于合成软海绵素大环内酯的大环化反应以及中间体和其他片段
JP6889232B2 (ja) ハリコンドリンbの類縁体の合成において有用な大環化反応および中間体
JP7440563B2 (ja) ハリコンドリンマクロライドおよびその類縁体の合成に有用なプリンス反応および中間体
JP7469226B2 (ja) ハリコンドリンマクロライドとそのアナログの合成に有用なプリンス反応及び化合物
RU2777913C2 (ru) Реакция принса и промежуточные продукты, применимые при синтезе макролидов галихондринового ряда и их аналогов
RU2813146C2 (ru) Реакция принса и соединения, применяемые в синтезе макролидов галихондрина и их аналогов
Mears et al. Synthesis of the C1–C16 fragment of bryostatin for incorporation into 20, 20-fluorinated analogues

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant